A new way to map how cells choose their fate

Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...
The New York Times

First Day of a ‘New Life’ for a Boy With Sickle Cell

Kendric Cromer, 12, is among the first patients to be treated with gene therapy just approved by the F.D.A. that many other patients face obstacles to receiving. By Gina Kolata Photographs by Kenny ...
The New England Journal of Medicine

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats ...